MultiBac System-Based Purification and Biophysical Characterization of Human Myosin-7a
August 23rd, 2024
This protocol details the procedures for recombinantly producing the human myosin-7a holoenzyme using the MultiBac Baculovirus system and for studying its motility using a tailored in vitro filament gliding assay.
We're trying to answer why mutations in myosin motors cause human disease and what roles these proteins play in the hearing process. Our research focuses on understanding the molecular mechanisms of Myosin-7a and how it works with Usher proteins to assemble and maintain the cellular machinery required for hearing. Understanding the structural and functional mechanisms of Myosin-7a requires high-quality intact protein, which has been a longstanding challenge in the field.
Recently, we made significant progress and successfully purified the full-length Myosin-7a hollow enzyme, allowing for further investigation of this important protein. With this protein now available, we can investigate key features of this motor including its structure, force generation and its motility. These insights are crucial for understanding the mechanisms of Myosin-7a in hearing and the molecular defects that lead to deafness in human patients.
In the future, our lab will leverage our expertise in the multi vac system to recombinantly produce large biomolecular complexes, for example the Usher 1 complex, which is critical for human sensory functions. This approach will enable us to determine their structures and the principles underlying their roles in sensory cells.
Overview
This protocol details the procedures for recombinantly producing the human myosin-7a holoenzyme using the MultiBac Baculovirus system and for studying its motility using a tailored in vitro filament gliding assay. Understanding the structural and functional mechanisms of Myosin-7a is crucial for elucidating its role in hearing and the molecular defects that lead to deafness.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Protein Biochemistry
Background
- Myosin motors are essential for various cellular processes.
- Mutations in myosin proteins are linked to human diseases, including hearing loss.
- Myosin-7a interacts with Usher proteins to maintain cellular machinery for hearing.
- Purifying high-quality Myosin-7a has been a challenge in the field.
Purpose of Study
- To produce the full-length Myosin-7a holoenzyme for research.
- To investigate the structural and functional properties of Myosin-7a.
- To understand the mechanisms behind hearing and deafness.
Methods Used
- Recombinant production using the MultiBac Baculovirus system.
- In vitro filament gliding assay to study motility.
- Purification techniques for obtaining high-quality protein.
- Structural analysis to investigate force generation and motility.
Main Results
- Successful purification of the Myosin-7a holoenzyme.
- Insights into the structure and function of Myosin-7a.
- Understanding of how Myosin-7a contributes to hearing processes.
- Identification of molecular defects leading to deafness.
Conclusions
- The study provides a foundation for future research on Myosin-7a.
- Findings may lead to better understanding of hearing loss mechanisms.
- Insights gained could inform therapeutic strategies for deafness.
Frequently Asked Questions
Executive Industry Relevance
Access to milligram quantities of high-purity, full-length human myosin-7a enables rigorous mechanistic studies critical for target validation in sensory biology. The MultiBac system-based workflow supports reproducible production and biophysical characterization, directly addressing longstanding bottlenecks in protein quality and supply for early discovery. This capability underpins predictive confidence in mechanistic de-risking and informs portfolio decisions for hearing and vision disorder research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of myosin-7a’s mechanistic role in sensory cell function.
- Supports functional target validation by providing intact, multimeric protein complexes.
- Facilitates predictive de-risking of molecular hypotheses related to Usher syndrome.
Screening & Assay Development
- Provides validated protein for quantitative in vitro motility and force generation assays.
- Enables assay standardization and reproducibility for downstream compound evaluation.
- Supports scalable production for platform reuse in screening campaigns.
Translational & Preclinical Research
- Aligns with disease-relevant systems by modeling native myosin-7a complexes.
- Enables continuity from molecular mechanism to preclinical model development.
- Supports risk-adjusted advancement of sensory disorder targets.
Pipeline & Workflow Integration
This method integrates at the interface of early discovery and lead identification, providing foundational reagents and quantitative outputs for mechanistic studies and assay development.
- Discovery Biology: Supplies intact myosin-7a for hypothesis testing and pathway clarification in sensory cell biology.
- Screening: Delivers reproducible, quantitative motility and force readouts for assay readiness.
- Analytics: Enables biophysical measurements that compare wild-type and mutant protein function.
- Translational Research: Supports modeling of disease-relevant complexes for preclinical continuity.
- Enterprise Reuse: Establishes a reusable protein production and characterization platform for related targets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes protein production and assay workflows for reproducibility and scalability.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling robust mechanistic studies.
- Portfolio Impact: Supports risk-adjusted prioritization of sensory disorder targets and complexes.
Implementation Considerations
- Requires expertise in baculovirus expression and protein purification.
- Needs access to biophysical instrumentation for motility and force assays.
- Demands cross-team standardization for reproducible protein quality and assay outputs.
- May require adaptation for other multimeric or membrane-associated complexes.
- Protein yield and stability may vary with construct design and expression conditions.
